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Abstract
Pulmonary embolism was reported as one of possible complications after implantable cardioverter-defibrillator (ICD) 
lead implanting procedures. Pleural effusion, with fluid bloody in appearance and with predominance of granulocytes, 
can be a common resolution of lasting pulmonary embolism. In this paper we present a case of ICD lead exchange 
procedure causing pulmonary embolism and pleural effusion, with bloody lymphocytic fluid as its consequence, with 
good response to corticosteroids treatment.
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Introduction
Pulmonary embolism (PE) is a major clinical problem in 
clinical practice, though its exact epidemiology is difficult 
to determine [1]. Among many predisposing factors for ve-
nous thrombosis, an implantable cardioverter-defibrillator 
(ICD) device is not considered [2]. We present a case of 
a lead replacement procedure complicated by PE, pos-
sibly caused by blood clot detached from the removed 
electrode. PE then caused an infarction of the lung and 
a pleural Dressler-like syndrome. This case deals with 
less obvious cause, presentation and course of PE, all 
in one patient.
Case report
A 32-year-old man with hypertrophic cardiomyopathy diag-
nosed at the age of 14, with right ventricle outflow obstru-
ction, with an ICD device implanted in primary prevention, 
underwent a replacement of the defibrillating electrode 
due to its damage five weeks prior to the admission to our 
department. Before lead removal a possible blood clot on 
the defibrillating electrode was found in echocardiography 
examination. Ten days after the lead replacement procedu-
re the patient started to feel chest pain and dyspnea with 
cough; his fever spiked to 39°C. His condition worsened de-
spite ambulatory treatment with oral amoxicillin/clavulanic 
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acid. He was admitted to cardiology department with 
a suspicion of infective endocarditis. He received intrave-
nous ceftriaxon, clarithromycin and vancomycin. All blood 
cultures returned negative; in three echocardiography 
examinations, including transesophageal one, there were 
no signs of bacterial vegetation. Despite the treatment with 
antibiotics no clinical improvement was noticed after 14 
days and radiological progression in chest X-ray was ob-
served — peripheral consolidations in the basal segments 
of left lung were now accompanied by pleural effusion. 
A chest computed tomography (CT) scan was performed 
with conclusion of lung abscess and pleural empyema, 
so patient was referred to our pulmonology department.
Our radiologist, after reviewing the CT scan, found 
a filling defect within the left inferior pulmonary artery 
and its segmental branches with pulmonary infarction 
and pleural fluid (Figure 1), so pulmonary embolism was 
diagnosed. In transthoracic echocardiography both right 
heart chambers were dilated, there were evidences of 
pulmonary hypertension — tricuspid valve pressure gra-
dient was 40 mmHg, with shortening of acceleration time 
with a visible notch. Patient’s electrocardiogram (ECG) 
is shown in Figure 2. Patient was started on enoxapa-
rin 1 mg per kg two times a day. More than 4000 mL of 
pleural fluid was obtained in series of punctures — bloo-
dy appearance, with characteristics of exudation, 85% 
lymphocytes and 15% eosinophils, no neoplasm cells 
in the fluid, fluid cultures for bacteria and tuberculosis 
were negative. Because the effusion was constantly incre-
asing, a suspicion of pleural lymphocytic inflammation 
was made (a pleural Dressler-like syndrome) and patient 
was commenced with intravenous methylprednisolone 
40 mg daily. After two weeks of treatment almost com-
plete regression of pleural abnormalities was observed in 
a control CT scan and he was switched to oral prednisone 
30 mg daily. Pulmonary embolism was treated chronically 
with oral rivaroxaban.
Discussion 
An ICD device is recommended for primary prevention in 
patients with hypertrophic cardiomyopathy with moderate 
to high 5-year risk of sudden cardiac death [3]. Among 
many complication of this procedure, PE has been reported 
as highly undermined — a study showed that in 4-month 
observation, among 185 patients, 25% had a lead-related 
thrombi, one had a clinically significant pulmonary embo-
lism [4]; these observations are supported by many case 
reports [5, 6]. No exact data indicate the need of routine 
transesophageal echocardiography to detect lead-related 
Figure 1. Chest CT. Filling defect in the left pulmonary artery; in-
farction of left lower lobe; fluid in the left pleural space
Figure 2. ECG. Sinus rhythm 70 bpm, single ventricular extrasystole. Dextrocardia. First-degree atrioventricular block. Right bundle branch 
block. Pathologic Q-waves in leads II, III, aVF and V4–V6
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thrombi and of anticoagulation treatment in this group of 
patients [5]. It seems most cases remain asymptomatic 
and self-resolving [7].
When dealing with pleural effusion, many etiological 
factors are considered. PE in a large study was the cause 
in only 1.6% of all cases [8], although pleural effusion is 
present in 30 to 50% of patients with PE. The cytological 
characteristics of pleural fluid in PE is mostly bloody in 
appearance, with dominance of granulocytes, but in about 
40% of lymphocytes; also fluid eosinophilia should be con-
sidered as PE-suggesting [9]. In each case neoplasm and 
infections need to be ruled out. What we believe is that 
the infarction of lung tissue was the promoting factor for 
lymphocytic fluid and therefore inflammation, which led to 
recurring pleural effusion despite many pleural punctures. 
Eventually corticosteroids were used — we were basing on 
the same idea that stands for treating Dressler syndrome. 
Although impressively effective in this case, we do not re-
commend it as routine management; further investigation 
in the field is needed.
Conclusion
Pulmonary embolism should be suspected in patients after 
all sorts of lead-related procedures, even when symptom 
presentation is poor or unspecific.
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Streszczenie
Zatorowość płucna była opisywana jako możliwe powikłanie zabiegów wszczepiania elektrod implantowalnego kardio-
wertera-defibrylatora (ICD). Wysiękowy krwisty płyn to dość częste następstwo długo trwającej zatorowości, a charakter 
wysięku jest najczęściej granulocytarny. W pracy omówiono przypadek powikłanego zatorowością zabiegu wymiany 
elektrody ICD oraz limfocytarnego wysięku opłucnowego jako następstwa ostrej zatorowości leczonego glikokortykoste-
roidami.
Słowa kluczowe: ostra zatorowość płucna, ICD, wysięk opłucnowy
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